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Abstract Dimethylethanolamine (0.5-1 mM), added to serum- 
starved N1H 3T3 fibroblasts, stimulated DNA synthesis 11-32- 
fold, and it also greatly enhanced the relatively modest (15-20- 
fold) mitogenic effect of insulin. Ethanolamine and momomethy- 
lethanolamine alone had no effects on DNA synthesis, but they 
also enhanced the stimulatory effect of insulin, although less 
effectively than dimethylethanolamine did. Lower concentrations 
(2.5-5 ~tglml) of compound D 609 (tricyclo-9-yl-xanthogenate), 
which had no effects on phospholipase activities, synergistically 
enhanced the combined effects of ethanolamine analogs and 
insulin on DNA synthesis without affecting the synthesis of 
ethanolamine phospholipids. These results suggest hat ethano- 
lamine and its analogues, formed by phospholipase D-mediated 
hydrolysis of ethanolamine phospholipids, may have growth 
regulatory functions independent of their role as phospholipid 
precursors. 
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I. Introduction 
Recent reports from another [1] and our laboratory [2,3] 
demonstrated that in N IH  3T3 fibroblasts externally added 
choline phosphate can greatly enhance DNA synthesis parti- 
cularly in the presence of insulin. Although the significance of 
this phenomenon still remains to be elucidated, it would be 
important o know whether other intermediates of phospho- 
lipid metabolism can also regulate cell growth, and if yes, how 
it is related to phospholipid synthesis. Thus, a major goal of 
this work was to examine the possible mitogenic effects of 
ethanolamine and its analogs, which can be formed by phos- 
pholipase D-mediated hydrolysis of ethanolamine phospho- 
lipids [4,5]. 
The current dogma is that phospholipid precursors are es- 
sential for cell growth solely because of the increased need to 
synthesize phospholipids, important components of biomem- 
branes. Since increased phospholipid synthesis indeed accom- 
panies stimulated cell growth [6], it is difficult to provide evi- 
dence that water-soluble intermediates of phospholipid 
metabolism also affect mitogenesis by an independent mech- 
anism. Such evidence would include the demonstration that a 
portion of mitogenic activity of phospholipid intermediates i  
not accompanied by increased phospholipid synthesis. 
High (15-35 ~g/ml) concentrations of tricyclodecan-9-yl- 
xanthogenate (compound D 609) has recently been used to 
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Abbreviations." PtdCho, phosphatidylcholine; PtdEtn, phosphatidyl- 
thanolamine. 
inhibit phospholipase C-mediated hydro-lysis of phosphatidyl- 
choline (PtdCho) [7-11]. We have shown that at these con- 
centrations compound D 609 also inhibits phospholipase D
activity [12]. However, when we began to use compund D 609 
to study the role of phospholipase activities in cell growth 
regulation, it turned out that at lower concentrations this 
compound exhibits mitogenic activity. As we will show here, 
in N IH 3T3 fibroblasts dimethylethanolamine and, to less ex- 
tents, monomethylethanolamine a d ethanolamine ach can 
stimulate DNA synthesis, and compound D 609 is capable 
of enhancing the mitogenic effects of ethanolamine analogues 
without altering the rate of synthesis of phosphatidylethanol- 
amine (PtdEtn). 
2. Experimental procedures 
2.1. Materials 
Ethanolamine, monomethylethanolamine, dimethylethanolamine, 
choline phosphate and Dowex-50W(H +) were purchased from Sigma; 
compound D 609 was from Kamiya Biomedical Company; insulin 
was bought from Boehringer Mannheim; [2-14C]ethanolamine (50 
mCi/mmol), [methyl-14C]choline chloride (50 mCi/mmol), and 
[methyl-3H]thymidine (85 Ci/mmol) were from Amersham; and tissue 
culture reagents were purchased from GIBCO-BRL. 
2.2. Cell culture 
NIH 3T3 clone-7 fibroblasts, obtained from Dr. Douglas R. Lowy 
(National Cancer Institute, Bethesda, MD, USA), were cultured con- 
tinuously in Dulbecco's modified Eagle's medium supplemented with 
10% (v/v) fetal calf serum, penicillin (50 U/ml), streptomycin (50 ~tg/ 
ml) and glutamine (2 mM). 
2.3. Labeling of cellular DNA with [3H]thymidine 
NIH 3T3 fibroblasts were grown in 12-well tissue culture dishes to 
about 30% confluency in the presence of 10% serum, followed by 
incubation of fibroblasts in serum-free medium for 24 h. Subse- 
quently, fibroblasts were washed and then were treated (in serum- 
free medium) first with ethanolamine analogues and/or compound 
D 609 for 20 rain, followed by treatments with insulin (500 nM) in 
the continuous presence of the other agents for 16 h. Finally, incuba- 
tions were continued in the presence of [methyl-3H]thymidine (1.5 
laCi/well) for 60 min. Fibroblasts were washed twice with phos- 
phate-buffered saline and then four times with 5% trichloroacetic 
acid. The acid-insoluble material was redissolved in 0.3 M sodium 
hydroxide, and an aliquot was taken to measure DNA-associated 
3H activity in a liquid scintillation counter. 
2.4. Measurement of the synthesis of PtdCho and PtdEtn 
NIH 3T3 fibroblasts were grown as above, followed by treatments 
in serum-free medium with compound D 609 and insulin for 2 h in the 
presence of [14C]choline (1.12×106 dprrdwell; 50 I.tM choline) or 
[I4C]ethanolamine (1.22× 106 dprrdwell; 50 p.M ethanolamine). Phos- 
pholipids were separated as described earlier [13]. CDP-choline and 
CDP-ethanolamine were separated from other products on Silica Gel 
G thin-layer plates using the solvent system of 0.5% NaCl/methanol/ 
concentrated NH3 (50 : 50 : 5, v/v/v). Labeled choline, ethanolamine 
and their phosphorylated erivatives were separated on Dowex 
50W(H +) columns as indicated earlier [14]. 
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3.  Resu l ts  
We have previously reported [2] that in NIH 3T3 fibroblasts 
ethanolamine alone has no mitogenic effect, but it can signifi- 
cantly enhance the relatively modest stimulatory effect of in- 
sulin on DNA synthesis. As shown in Fig. 1, monomethyl- 
ethanolamine alone was also an ineffective inducer of DNA 
synthesis but it potentiated the mitogenic effect of insulin to 
an even greater extent han ethanolamine did. In contrast, 0.5 
and 1 mM concentrations of dimethylethanolamine e hanced 
DNA synthesis 12- and 33-fold, respectively, even in the ab- 
sence of insulin (Fig. 1). In addition, dimethylethanolamine 
more effectively potentiated the mitogenic effect of insulin 
than the other ethanolamine compounds (Fig. 1). Interesting- 
ely, despite the observed ifferences in their mitogenic poten- 
cies, each ethanolamine analogue was maximally effective at 
1 mM concentration. Using these compounds at 1.5 or 2 mM 
concentrations resulted in slightly less mitogenic activity, 
while 5 mM monomethylethanolamine or diethylethanola- 
mine strongly inhibited the mitogenic effect of insulin (data 
not shown). We suspect hat high concentrations of ethanol- 
amine analogs hift the cellular pH upward to a point which is 
unfavorable for the mitogenic action of insulin. However, this 
point remains to be verified. 
The combined mitogenic effects of insulin and ethanolamine 
analogues were inhibited by both 100 nM wortmannin (55- 
60% inhibition) and 0.5 mM 8-bromo cyclic AMP (~90% 
inhibition), but not by the protein kinase C inhibitor GF 
109203X (data not shown). In contrast, the combined mito- 
genic effects of choline phosphate and insulin were not inhib- 
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Fig. 1. Concentration-dependent effects of ethanolamine analogues 
on DNA synthesis in NIH 3T3 fibroblasts. Serum-starved (24 h) 
subconfluent fibroblasts were treated for 16 h with 0.1 1 mM con- 
centrations of ethanolamine (O-O), monomethylethanolamine (~ 
A), or dimethylethanolamine (D-U) in the absence (open symbols) 
or presence (closed symbols) of 500 nM insulin. Each point repre- 
sents the mean+ S.E. of six experiments performed with the same 
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Fig. 2. Concentration-dependent effects of compound D 609 on 
DNA synthesis nduced by choline phosphate and insulin. Serum- 
starved subconfluent NIH 3T3 fibroblasts were treated with 1-5 gg/ 
ml concentrations of compound D 609 for 16 h in the absence ( ) 
or presence of 500 nM insulin (A), 1 mM choline phosphate (11), or 
insulin plus choline phosphate (,). Each point represents he 
mean + S.E. of six experiments performed with the same passage of 
cells. These potentiating effects of D 609 were confirmed in 15 addi- 
tional experiments. 
choline phosphate potentiate the mitogenic effects of insulin 
through wortmannin-sensitive and- insensitive mechanisms, 
respectively. 
During this study we found that low (1-5 ~g/ml) concen- 
trations of D 609, which do not modify phospholipase activ- 
ities [12], can greatly enhance the mitogenic effect of insulin; 
this is shown in Fig. 2. In addition, compound D 609 was also 
found to potentiate the effect of choline phosphate and the 
synergistic effects of insulin and choline phosphate on DNA 
synthesis (Fig. 2). Parallel to their synergistic actions on DNA 
synthesis, insulin and compound D 609 (5 ~tg/ml) also en- 
hanced, in a slightly synergistic manner, the synthesis of 
CDP-choline (Fig. 3A) and PtdCho (Fig. 3B). Since PtdCho 
synthesis i required for cell cycle progression [15], these latter 
data may be interpreted to mean that compound D 609 en- 
hanced the mitogenic activity of insulin by increasing PtdCho 
synthesis. However, this point remains to be verified. 
In contrast o PtdCho synthesis, the synthesis of PtdEtn 
was not affected by compound D 609; this compund actually 
inhibited the small stimulatory effect of insulin (Fig. 3D). 
Compound D 609 also failed to modify the formation of 
PtdCho from PtdEtn through the methylation pathway which 
was examined in [14C]ethanolamine-labeled fibroblasts (data 
not shown). Thus, it was of interest o determine whether 
compound D 609, despite its inability to stimulate PtdEtn 
synthesis or methylation of PtdEtn, was able to enhance the 
mitogenic effects of ethanolamine analogues. As shown in Fig. 
4, a lower (2.5 ~tg/ml) concentration of compound D 609 
clearly synergistically enhanced the mitogenic effects of each 
ethanolamine analogue. Similar potentiating effects were also 
observeable, although they were somewhat less evident, at the 
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higher (5 ~g/ml) concentration f compound D 609 used (Fig. 
4). Importantly, in the absence of insulin, 5 ~g/ml of com- 
pound D 609 also enhanced the mitogenic effects of 0.5 and 
1 mM concentrations of dimethylethanolamine 3.2- and 4.1- 
fold, respectively. Thus, potentiation of the mitogenic effects 
of this ethanolamine analogue by compound D 609 does not 
require the presence of insulin. 
4. D iscuss ion 
A major finding of this paper is that addition of dimethyl- 
ethanolamine to fibroblasts induced DNA synthesis on its 
own, and it also greatly enhanced the mitogenic effect of in- 
sulin. Many physiological stimuli increase methylation of 
PtdEtn (reviewed in ref. [16]), and phosphatidyl-N,N- 
dimethylethanolamine is a more effective phospholipase D 
substrate than PtdCho [17]. This raises the testable possibility 
that concomitant activation of PtdEtn methyltransferase nd 
phospholipase D can result in the formation of sufficient 
amounts of dimethylethanolamine to stimulate cell growth. 
As an example, the protein kinase C activator phorbol 12- 
myristate 13-acetate has been shown to stimulate the activity 
of both PtdEtn methyltransferase [18 20] and phospholipase 
D [4] in fibroblasts and other cell types. Preliminary experi- 
ments in this laboratory indicate that potentiation of the mi- 
togenic effect of insulin by phorbol ester [3] can be inhibited 
by 1 mM 3-deazaadenosine, a well known inhibitor of methyl 
transferase [21], implying the role of methylated ethanolamine 
analogs in the mediation of co-mitogenic effects of phorbol 
ester. 
Since ethanolamine and its analogues are incorporated into 
phospholipids, it would be tempting to ascribe their mitogenic 
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Fig. 3. Effects of D 609 and insulin on the synthesis of PtdCho and 
PtdEtn in NIH 3T3 fibroblasts. Serum-starved fibroblasts, grown in 
12-well culture dishes, were incubated with [14C]choline (A and B) 
or [~4C]ethanolamine (C and D) for 2 h in the absence (open bar) 
or presence of 500 nM insulin (striped bar), 5 ~g/ml of D 609 (cross 
hatched bar), or insulin plus D 609 (solid bar). Data represent the 
mean _+ S.E.M. of nine experiments performed with the same passage 
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Fig. 4. Combined synergistic effects of ethanolamine analogues, in- 
sulin, and compound D 609 on DNA synthesis n NIH 3T3 cells. 
Serum-starved fibroblasts were treated with 500 nM insulin for 16 h 
in the absence (open bar) or presence of 1 mM ethanolamine 
(striped bar), 1 mM monomethylethanolamine (cross hatched bar), 
0.5 mM dimethylethanolamine (stippled bar), or l mM dimethyl- 
ethanolamine (solid bar). Compound D 609 was either absent (A), 
or it was present at a concentration of 2.5 ug/ml (B) or 5 ktg/ml. 
Data represent the mean + SE of six experiments performed with the 
same passage of cells. These results were confirmed in six additional 
experiments. 
pound D 609 was able to potentiate the mitogenic effects of 
ethanolamine analogues without affecting the synthesis of 
PtdEtn and its methylated forms. This indicates that ethanol- 
amine analogues can enhance DNA synthesis by a mechanism 
which is not mediated by increased synthesis of PtdEtn and its 
methylated derivatives. Collectively, these observations justify 
further examination of the possible growth regulatory role of 
dimethylethanolamine in vivo. 
The mechanism by which ethanolamine analogues enhance 
DNA synthesis i presently not known. However, considering 
that growth factor effects are extremely sensitive to changes in 
intracellular pH, ethanolamine analogues might act by slightly 
enhancing intracellular pH. We are presently examining this 
and other possibilities. 
Recently, we have demonstrated that concentrations of
compund D 609 which inhibit PtdCho-specific phospholipase 
C activity also inhibit phospholipase D activity [12]. Here we 
showed that lower concentrations of compound 609 exhibit 
co-mitogenic effects, which reinforces our previous conclusion 
that compound D 609 cannot be used as a specific inhibitor of 
phospholipase C [12]. However, the use of this compound in 
this work helped to clarify the absence of causal relationship 
between the mitogenic effects of ethanolamine analogues and 
phospholipid synthesis. It remains to be seen whether this 
compound will be similarly useful in the study of other aspects 
of signal transduction. 
In summary, we showed that dimethylethanolamine, which 
can be formed by the concerted actions of activated methyl- 
transferase and phospholipase D, is a mitogen in NIH 3T3 
fibroblasts. Evidence is also presented to indicate that the 
mitogenic actions of ethanolamine analogues are unrelated, 
at least in part, to their role as precursors for phospholipid 
synthesis. Further work is required to determine the possible 
role of dimethylethanolamine in the regulation of cell growth 
in vivo. 
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